Origin Trial Investigators

Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE)

Origin Trial Investigators, 2015, Diabetes Care.

Predictors of Nonsevere and Severe Hypoglycemia During Glucose-Lowering Treatment With Insulin Glargine or Standard Drugs in the ORIGIN Trial

Origin Trial Investigators, 2014, Diabetes Care.

Characteristics Associated With Maintenance of Mean A1C <6.5% in People With Dysglycemia in the ORIGIN Trial

Origin Trial Investigators, 2013, Diabetes Care.